Cryo-Cell International Inc.

NYSE

Currency in USD
3.35
-0.11 (-3.18%)

Real-time Data

01:30 PM

Day's Range

3.35
3.35

52 wk Range

2.72
5.43
Loading

Key Statistics

Symbol

CCEL

Name

Cryo-Cell International Inc.

Currency

USD

Exchange

NYSE

High

3.35

Low

3.35

Open

‪3.35‬

Last

‪3.35‬

Market Cap

27.89M

Pe Ratio

‪475.00‬

Volume

8

Average Volume

6.42K

Dividend Yield

‪4.29%‬

Change

-0.11

Percent Change

-3.18

Timestamp

2026-07-20

Close

3.35

Today Range Start

‪3.35‬

Today Range End

‪3.35‬

52 Week Range Start

‪2.72‬

52 Week Range End

‪5.43‬

Type

Stocks

Country

United States

Compliance - CCEL - Cryo-Cell International Inc.

Compliance

Status

COMPLIANT

Report Date

2025-02-20

Business Screen

COMPLIANT

Financial Screen

COMPLIANT

Compliant Revenue

‪98.00%‬

Non Compliant Revenue

‪2.00%‬

Questionable Revenue

‪0.00%‬

Securities To Market Cap Ratio

‪10.00%‬

Debt To Market Cap Ratio

‪10.00%‬

Historical Data - CCEL - Cryo-Cell International Inc.

Historical Data

TimeOpenHighLowCloseVolume

No data available

Market Cap - CCEL - Cryo-Cell International Inc.

Market Cap

2026-07-17

27.89M

2026-07-16

28.03M

2026-07-15

28.79M

2026-07-14

27.38M

2026-07-13

28.19M

2026-07-10

27.54M

2026-07-09

28.50M

2026-07-08

27.65M

2026-07-07

28.75M

2026-07-06

29.07M

Dividend - CCEL - Cryo-Cell International Inc.

Dividend

2025-05-21

0.1500

Earnings - CCEL - Cryo-Cell International Inc.

Earnings

DateTimeEPS EstimateEPS ActualDifferenceSurprise PRC
2026-07-15--0.07--
2026-04-14--0.020.020.04‪-200.00%‬
2026-02-27--0.09-0.47-0.38‪+422.22%‬
2026-01-23-1.611.870.26‪+16.15%‬

Balance Sheet - CCEL - Cryo-Cell International Inc.

Balance Sheet

Period Ending2025-11-302024-11-302023-11-302022-11-302021-11-302020-11-30
ExpandAssets
61.72M64.67M61.22M64.88M60.66M46.20M
ExpandLiabilities
80.33M77.89M72.25M66.41M56.47M48.86M
ExpandShareholders Equity
-18.60M-13.21M-11.03M-1.52M4.18M-2.66M

Cash Flow - CCEL - Cryo-Cell International Inc.

Cash Flow

Period Ending2025-11-302024-11-302023-11-302022-11-302021-11-302020-11-30
ExpandOperating Activities
------
ExpandInvesting Activities
------
ExpandFinancing Activities
------
End Cash Position319.03K560.96K406.06K1.70M8.26M10.36M
Income Tax Paid4.59M2.71M1.82M1.57M3.53M-
Interest Paid2.02M1.97M1.80M1.25M1.03M-
Free Cash Flow5.24M2.40M1.28M-8.59M974.92K8.01M

Income Statement - CCEL - Cryo-Cell International Inc.

Income Statement

Period Ending2025-11-302024-11-302023-11-302022-11-302021-11-302020-11-30
Sales31.56M31.98M31.34M30.33M28.88M31.14M
Cost of Goods7.37M7.94M8.44M8.79M8.98M9.65M
Gross Profit24.18M24.03M22.90M21.54M19.89M21.49M
ExpandOperating Expense
------
Operating Income4.84M3.78M3.49M4.45M4.40M7M
ExpandNon-Operating Interest
------
Other Income Expense-5.11M880.52K-15.61M380.91K-410.09K-422.29K
Pre Tax Income-2.33M2.80M-13.36M3.31M2.61M5.03M
Income Tax92.23K2.40M-3.84M547.54K527.71K1.41M
Net Income-2.42M402.09K-9.52M2.77M2.08M3.62M
EPS Basic-0.30.05-1.140.330.260.48
EPS Diluted-0.30.05-1.140.330.250.45
Basic Shares Outstanding8.06M8.13M8.34M8.46M8.13M7.54M
Diluted Shares Outstanding8.06M8.13M8.34M8.46M8.13M7.54M
Ebit-270.89K4.66M-12.12M4.84M3.99M6.58M
Ebitda6.26M4.81M5.20M6.27M5.72M7.64M
Net Income Continuous Operations-2.42M402.09K-9.52M2.77M2.08M3.62M
Minority Interests------
Preferred Stock Dividends------

Recommendations - CCEL - Cryo-Cell International Inc.

Recommendations

DateStrong BuyBuyHoldSellStrong Sell
Jul 202600100
Jun 202600100
May 2026-----
Apr 2026-----

Profile - CCEL - Cryo-Cell International Inc.

Profile

Mic Code

XASE

Sector

Healthcare

Industry

Medical Care Facilities

Employees

72


Cryo-Cell International Inc. is a prominent biotechnology company that specializes in cord blood and tissue banking services. Established with a focus on providing families with the opportunity to preserve vital biological resources, Cryo-Cell collects and stores umbilical cord blood and tissue at the time of a child's birth. These stored cells can potentially be used in future medical treatments due to their ability to differentiate into various cell types. The primary purpose of Cryo-Cell is to offer reliable and accessible solutions for parents wishing to safeguard their children's health against potential future illnesses, such as blood disorders and certain genetic diseases. Operating within the healthcare and biotech sectors, Cryo-Cell International Inc. plays a crucial role in the rapidly evolving field of regenerative medicine, contributing to advancements in cellular therapies and research. With its headquarters in Oldsmar, Florida, the company is a significant participant in the biotechnology industry, known for its emphasis on innovation, quality control, and adherence to rigorous industry standards. As a trusted entity in its domain, Cryo-Cell remains committed to expanding its scientific capabilities and enhancing the scope of its services, thereby impacting the broader medical and scientific communities.

Profile Details

Type

Common Stock

Address

700 Brooker Creek Boulevard

City

Oldsmar

State

FL

Zip

34677

Country

United States

Phone

813 749 2100

Related news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.
Cryo-Cell International Inc. (CCEL - NYSE) Price Today | UA Finance